Filing Details

Accession Number:
0001104659-24-082630
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-07-25 16:05:09
Reporting Period:
2024-07-23
Accepted Time:
2024-07-25 16:05:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1400118 Sagimet Biosciences Inc. SGMT Pharmaceutical Preparations (2834) 205991472
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1858176 George Kemble Sagimet Biosciences Inc.
155 Bovet Rd., Suite 303
San Mateo CA 94402
Executive Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Series A Common Stock Disposition 2024-07-23 23,625 $3.17 118,693 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. These sales were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2024.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.07 to $3.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.